Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00049998
Status:
COMPLETED
Last Update Posted:
2013-03-04
First Post:
2002-11-18
Brief Title:
Oral Topotecan Versus Intravenous Docetaxel In Pretreated Advanced Non-Small Cell Lung Cancer
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-10
Start Date Type:
None
Primary Completion Date:
2004-04
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2002-11-18
First Submit QC Date:
November 19 2002
Study First Post Date:
2002-11-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-03-01
Last Update Post Date:
2013-03-04
Last Update Post Date Type:
ESTIMATED